| Vol. 12.07 – 23 February, 2021 |
| |
|
|
| Cetuximab‐conjugated maleimide‐polyethylene glycol‐chlorin e6 (CMPC) was designed to strengthen its antitumor efficacy. With a strong affinity for epidermal growth factor receptor overexpressing Aspc‐1 cells, CMPC with laser exerted the greatest cytotoxicity and induction of immunogenic cell death. [Small] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| Interleukin (IL)‐33 was highly expressed in the skin and pancreatic epithelial cells in chronic inflammation, leading to a markedly repressed Smad6 expression as well as dramatically upregulated p‐SMAD2/3 and p‐SMAD1/5 in the epithelial cells. [EMBO Journal] |
|
|
|
| The authors revealed that control of the expression of KRAS and its effectors regulated the sensitivity of acinar cells to transformation by oncogenic Kras mutations. [Cancer Research] |
|
|
|
| Researchers found that a Ser552Ala version of β-catenin attenuated glucose stimulated insulin secretion indicating a functional role for Ser552 phosphorylation of β-catenin in insulin secretion. [Biochemical Journal] |
|
|
|
| The authors compared and discussed two strategies for culturing human pancreatic β-cells derived from human induced pluripotent stem cells in microfluidic biochips. [Journal of Biotechnology] |
|
|
|
|
| Investigators showed that interferon signaling, present in a subset of PDAC tumors, substantially lowered NAD(H) levels through up-regulating the expression of NAD-consuming enzymes PARP9, PARP10, and PARP14. [Proceedings of the National Academy of Sciences of the United States of America] |
|
|
|
| Cx43, the most widely expressed connexin, regulates cell behaviors, including migration and proliferation. Scientists hypothesized that Cx43 could regulate PDAC progression. [Oncogene] |
|
|
|
| Scientists showed that ubiquitin carboxyl-terminal hydrolase L3 (UCHL3) expression was significantly increased in the pancreatic cancer tissues and cells, and that knocking down UCHL3 noticeably inhibited cell viability and aerobic glycolysis. [Clinical and Translational Oncology] |
|
|
|
| Researchers investigated whether fucoxanthinol (FxOH), induced apoptosis in human pancreatic cancer cells. FxOH significantly promoted the growth of human pancreatic cancer PANC-1 cells. [Nutrition and Cancer] |
|
|
|
|
| The authors assess the current understanding of mechanisms of gene expression dysregulation. They focus on four drivers of gene expression dysregulation, including mutations, transcription factors, epigenetic regulators, and RNA stability/isoform regulation, in the context of PDAC pathogenesis. [Trends in Cancer] |
|
|
|
| New drug combinations and new concepts to improve drug delivery into the tumor, as well as the development of preclinical predictive assays, are being explored and provide optimism and prospects for better therapies. [International Journal of Molecular Sciences] |
|
|
|
|
| JDRF announced, in collaboration with the Harvard Stem Cell Institute, the launch of the JDRF Center of Excellence in New England. [JDRF (PR Newswire, LLC)] |
|
|
|
| Darling Ingredients, Inc. announced that its Rousselot Biomedical brand is joining the European project ENLIGHT. Researchers from academic centers and leading industries across Europe are joining forces to develop a living model of the pancreas to enable better testing of diabetes medication. [Darling Ingredients, Inc.] |
|
|
|
|
| June 21 – 26, 2021 Virtual |
|
|
|
|
|
| Rutgers Robert Wood Johnson Medical School – Rutgers, New Jersey, United States |
|
|
|
| Baylor College of Medicine – Houston, Texas, United States |
|
|
|
| Gilead Sciences, Inc. – Foster City, California, United States |
|
|
|
| The Francis Crick Institute – London, England, United Kingdom |
|
|
|
| Institute of Physiology – Prague, Czech Republic |
|
|
|
|